Back

Safety and efficacy of potassium binders on hyperkalemia: a novel systematic review and meta-analysis of randomized controlled trials

31 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Heart failure pharmacotherapy updates Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Maite Werlang

Rio Do Sul (Brazil)

3 More presentations in this session

Presentation thumbnail
Gender differences in mortality benefit of raas inhibitors in heart failure: a retrospective cohort study
Doctor V. Copeland (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
6 years of ARNI use in Israel - effectiveness analysis in real world data
Professor Z. Iakobishvili (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Impact of sodium-glucose co-transporter 2 inhibition on right ventricular function and pulmonary artery systolic pressure across heart failure phenotypes: a meta-analytic approach
Doctor M. Patricio (Manila, PH)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure pharmacotherapy updates

The Event

Event poster

ESC Congress 2025

31 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular mortality with oral potassium-binders in patients with CKD and heart failure
thumbnail
Congress Presentation
Clinical practice associated with 6-month use of patiromer in patients with heart failure
thumbnail
Congress Presentation
Patiromer use for the treatment of hyperkaliemia in patients with heart failure and chronic kidney disease, real-world experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources